Financial statements Passio Biomaterials
Balance sheet data of PASSIO BIOMATERIALS
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 487 594,51 | 1 451 371,33 | 1 785 208,38 | 1 953 302,72 | 1 952 396,68 |
| A. Fixed assets | 359 109,49 | 316 311,38 | 313 516,10 | 312 148,46 | 312 148,46 |
| B. Current assets | 1 128 485,02 | 1 135 059,95 | 1 471 692,28 | 1 641 154,26 | 1 640 248,22 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 487 594,51 | 1 451 371,33 | 1 785 208,38 | 1 953 302,72 | 1 952 396,68 |
| A. Equity | 1 156 781,54 | 1 109 796,08 | 1 221 084,61 | 1 203 644,25 | 1 235 129,54 |
| B. Liabilities and provisions for liabilities | 330 812,97 | 341 575,25 | 564 123,77 | 749 658,47 | 717 267,14 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.